Caina Technology Co., Ltd.

Shenzhen Stock Exchange 301122.SZ

Caina Technology Co., Ltd. Current Liabilities for the year ending December 31, 2023: USD 15.64 M

Caina Technology Co., Ltd. Current Liabilities is USD 15.64 M for the year ending December 31, 2023, a 9.08% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.
  • Caina Technology Co., Ltd. Current Liabilities for the year ending December 31, 2022 was USD 14.34 M, a -6.77% change year over year.
  • Caina Technology Co., Ltd. Current Liabilities for the year ending December 31, 2021 was USD 15.38 M, a 8.77% change year over year.
  • Caina Technology Co., Ltd. Current Liabilities for the year ending December 31, 2020 was USD 14.14 M, a -11.51% change year over year.
  • Caina Technology Co., Ltd. Current Liabilities for the year ending December 31, 2019 was USD 15.98 M, a 1.35% change year over year.
Key data
Date Current Liabilities Total Non-Current Liabilities Shareholders' Equity Long-Term Debt
Market news
Shenzhen Stock Exchange: 301122.SZ

Caina Technology Co., Ltd.

CEO Mr. Jun Lu
IPO Date Jan. 26, 2022
Location China
Headquarters No. 23, Huaxi Road
Employees 689
Sector Health Care
Industries
Pharmaceuticals Biotechnology Medical Instruments
Description

Caina Technology Co., Ltd. engages in the research, development, production, and sale of injection needles, syringes and other related medical devices. It offers disposable sterile safe self-destructing syringes, disposable insulin syringes, disposable sterile insulin pen needles, disposable sterile blood collection needles, and other sterile medical devices. The company was founded in 2004 and is based in Jiangyin, China.

StockViz Staff

January 15, 2025

Any question? Send us an email